DAWN BEGNER: Open Payments
NPI 1053041251 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 16 payments from 8 companies in 2025. Trend: 2023 $1,356 · 2024 $926 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 5 | $148 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $67 |
| ABBVIE INC. | 2 | $39 |
| Lundbeck LLC | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Tris Pharma Inc | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: SPRAVATO, CAPLYTA, INVEGA SUSTENNA, VRAYLAR, REXULTI, Auvelity, Dyanavel XR, Qelbree.
Industry payments across MS — which companies pay providers there.
